case_images: PMC10397489_01
case_images: Early gastric cancer not indicated for endoscopic treatment is found on the posterior wall of the stomach.
case_images: CRIGM2023-5620348.001.jpg
case_images: PMC10397489_01_CRIGM2023-5620348.001.jpg
case_images: fig1
case_images: EGD was performed to obtain a detailed evaluation of the posterior wall lesion, which revealed that the lesion was not suitable for endoscopic treatment (Figure 1).
case_images: Since several hemostatic clips are used, identifying the bleeding points is difficult.
case_images: CRIGM2023-5620348.002.jpg
case_images: PMC10397489_01_CRIGM2023-5620348.002.jpg
case_images: fig2
case_images: We attempted to achieve hemostasis using clips, but the bleeding point shifted as more clips were added, which resulted in multiple hemostatic clips (Figure 2).
case_images: (a) A dedicated catheter is used to apply PuraStat to the approximate bleeding site. (b) Primary hemostasis is confirmed.
case_images: CRIGM2023-5620348.003.jpg
case_images: PMC10397489_01_CRIGM2023-5620348.003.jpg
case_images: fig3
case_images: PuraStat over the approximate bleeding site (Figure 3(a)). Primary hemostasis was confirmed (Figure 3(b)).
case_images: Endoscopic findings 2 hours after PuraStat application. The whitened gel remains intact, and complete hemostasis is achieved.
case_images: CRIGM2023-5620348.004.jpg
case_images: PMC10397489_01_CRIGM2023-5620348.004.jpg
case_images: fig4
case_images: Although we rinsed the gel with a water jet, the white-turning PuraStat gel remained firmly in the applied area, confirming that complete hemostasis had been achieved (Figure 4).